Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Taiwan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20172
20185
20202
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical4
Genzyme, a Sanofi Company2
Kastle Therapeutics, LLC2
Pfizer2
Regeneron Pharmaceuticals2
4D Molecular Therapeutics1
Intellia Therapeutics1
National Taiwan University Hospital1
PTC Therapeutics1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn17
Blood Coagulation Disorders, Inherited7
Coagulation Protein Disorders7
Hematologic Diseases7
Hemophilia A7
Hemorrhagic Disorders7
Blood Coagulation Disorders6
Metabolic Diseases6
Metabolism, Inborn Errors5
Hemostatic Disorders4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.